Friday, July 01, 2011

Nominations Open Richard Lane/Robert Holden Patient Advocacy Award

National Alliance for Medication Assisted Recovery
Press Release

Contact Persons:
Joycelyn Woods, Executive Director,
Roxanne Baker, President,
Phone/Fax: 212-595-NAMA

For Release:
July 1, 2011

Nominations Open
Richard Lane/Robert Holden Patient Advocacy Award

NAMA Recovery is proud to announce that nominations are now open for the Richard Lane and Robert Holden Patient Advocacy Award.

The History

Richard Lane was a long-term heroin user who, upon release from prison in 1967, was instrumental in establishing one of the Nation’s first methadone treatment programs, ManAlive in Baltimore, Maryland. In 1974, he became the Executive Director of ManAlive and remained in that position until his death in 1994. He also served as Vice President of the American Methadone Treatment Association (now AATOD) and as Vice Chairman of the Governor’s Council on Alcohol and Drug Abuse in Maryland. Richard was a passionate advocate for methadone treatment and, by disclosing his own treatment experiences, provided inspiration to patients and colleagues alike.

Robert Holden was also a recovering heroin user, who later became the Director of PIDARC, an outpatient methadone treatment program in the District of Columbia. He was a friend of Richard Lane and succeeded Richard Lane’s term of office as the Vice President of the American Association for the Treatment of Opioid Dependence.

This award was established in 1995 and recognizes extraordinary achievements in patient advocacy.

The Criteria for Nomination

The following criteria should be applied in making your selection:

  • Only one (1) nominee can be submitted to the Conference Awards Committee. There may be a number of nominees, who will be fielded by NAMA Recovery in the medication assisted treatment MAT (i.e. methadone and/or buprenorphine) patient advocacy movement, however, NAMA Recovery will be responsible for submitting only one (1) “consensus” nominee to receive this honor.

  • The nominee must have been involved in the field of methadone and/or buprenorphine advocacy for a period of five (5) years.

  • The nominee must have been actively engaged in methadone and/or buprenorphine advocacy for a period of five (5) years.

  • The nominee must have made meaningful and consistent contributions, which have had a significant impact on opioid treatment within a state or region of the United States.

  • For each nominee a Nomination Form must be completed and submitted with two (2) Letters of Support. The Nomination Form is included with this announcement and can also be downloaded from the NAMA Recovery website:

  • Additional information about the award can be found at the NAMA Recovery website

  • NAMA Recovery will be responsible for collecting all the submissions for nomination including a Selection Committee that will decide on the final candidate. The Candidate’s Name, Nomination Form and at least two (2) Letters of Support describing the nominee’s achievements will be submitted to the Awards Committee for the final approval.

  • The Deadline for Submission is Monday, August 22, 2011. The completed Nomination Form along with at least two (2) Letters of Support should be sent to Joycelyn Woods at

Previous Winners of the Award

1995, Arizona Richard Lane
2001, St. Louis Joycelyn Woods
2007, Atlanta Anthony Scro
2009, New York Walter Ginter
2010, Chicago Lisa Mojer-Torres

This Award will be bestowed upon the recipient at the Awards Banquet Ceremony during AATOD's next National Conference which will convene in Las Vegas.

The recipient will be provided with a roundtrip Coach Class airfare in addition to up to two (2) nights in the hotel. The individual will also be able to attend the Conference (May 5-9, 2011).

Deadline: August 22, 2011
Email Nominations To: Joycelyn Woods

If you have any questions about the award contact Joycelyn Woods at or by telephone at (718) 742-7804.

Download Press Release

Download Nomination Form

Download Criteria

Go to Award Webpage

No comments: